Anlon Healthcare Share Price | Anlon Healthcare Stock Screener
AHCL
Pharmaceuticals
Share Price NSE
₹15.95
▼
-0.35 (-2.15%)
Share Price BSE
₹15.96
▼
-0.34 (-2.09%)
As of June 22, 2026, the Anlon Healthcare share price (NSE: AHCL) is ₹15.95 on NSE and ₹15.96 on BSE, down 2.15% from the previous close, with shares trading between ₹15.90 and ₹16.75, and a 52-week range of ₹13.11–₹154.70.
Check AHCL 52-week performance for the annual price range and momentum.
Use the Anlon Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Anlon Healthcare Market Cap
₹854.10 Cr.
AHCL P/E Ratio (TTM)
29.24
Anlon Healthcare P/B Ratio
3.71
EPS (TTM)
₹5.93
Dividend Yield
-
Debt to Equity
1.46
AHCL 52 Week High
₹154.70
Anlon Healthcare 52 Week Low
₹13.11
Operating Margin
30.00%
Profit Margin
21.57%
AHCL Revenue (TTM)
₹51.00
EBITDA
₹15.00
Net Income
₹11.00
Total Assets
₹317.00
Total Equity
₹210.00
Anlon Healthcare Share Price Chart
Screen Anlon Healthcare share price with an interactive chart. Analyse AHCL price trends and volatility across different timeframes.
Anlon Healthcare Company Profile - Fundamental Screener
Screen Anlon Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AHCL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0Y8W01025
Anlon Healthcare Balance Sheet Screener
Screen AHCL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 317 | 181 | 128 | 112 | 85 | 71 |
| Current Assets | 260 | 159 | 101 | 86 | 58 | 40 |
| Fixed Assets | 40 | 23 | 27 | 26 | 27 | 29 |
| Liabilities | ||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 7 | 41 | 57 | 61 | 55 | 38 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 210 | 80 | 21 | 7 | 2 | 2 |
| Share Capital | 53 | 40 | 16 | 12 | 12 | 12 |
| Reserves & Surplus | 157 | 41 | 5 | -5 | -10 | -10 |
Anlon Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Anlon Healthcare income statement and profit fundamentals.
Analyze AHCL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Anlon Healthcare share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Dec |
|---|---|---|---|
| Revenue | 51 | 49 | 36 |
| Expenses | 36 | 32 | 23 |
| EBITDA | 15 | 17 | 13 |
| Operating Profit % | 30.00% | 35.00% | 35.00% |
| Depreciation | 0 | 1 | 0 |
| Interest | 1 | 1 | 2 |
| Profit Before Tax | 14 | 16 | 11 |
| Tax | 3 | -1 | 6 |
| Net Profit | 11 | 17 | 5 |
| EPS | 2.33 | 5.15 | 1.13 |
Anlon Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen AHCL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | -23 | -3 | -3 | -2 | -15 |
| Investing Activities | 3 | -3 | 0 | 0 | -3 |
| Financing Activities | 19 | 8 | 2 | 3 | 16 |
| Net Cash Flow | -1 | 2 | -1 | 1 | -2 |
Anlon Healthcare Shareholding Pattern Screener
See Anlon Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Anlon Healthcare promoter holding and ownership changes for AHCL on TickJournal.
| Item | 2026-Mar | 2025-Apr | 2025-Jun | 2025-Aug | 2025-Sept | 2025-Dec | 2024-Oct |
|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.68% | 70.26% | 52.68% | 70.26% | 52.68% | 52.68% | 70.26% |
| FII Holding | 0.32% | 0.00% | 14.42% | 0.00% | 0.00% | 0.23% | 0.00% |
| DII Holding | 4.60% | 0.00% | 4.35% | 0.00% | 2.83% | 4.49% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.38% | 0.00% | 14.64% | 0.00% | 20.73% | 23.58% | 0.00% |
| Other Holding | 18.02% | 29.74% | 13.92% | 29.74% | 23.75% | 19.02% | 29.74% |
| Shareholder Count | 12,484 | 131 | 9,125 | 135 | 9,126 | 11,412 | 109 |
Anlon Healthcare Share Dividend Screener - Share Yield Analysis
Check Anlon Healthcare dividend history with payout and yield data.
View Anlon Healthcare dividend details including ex-dates and amounts for AHCL stock.
Anlon Healthcare Stock Index Membership
See which indices include Anlon Healthcare stock.
Check AHCL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Anlon Healthcare Market Events Screener - Corporate Actions
Get Anlon Healthcare corporate actions including splits, bonuses, and buybacks.
Check Anlon Healthcare stock events that may affect AHCL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 2.59% |
| 2026-04-24 | 2026-04-24 | Bonus | 1:1 | 18.26% |
| 2026-04-24 | 2026-03-06 | Split | 2:10 | 0.00% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | 4.04% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 924.44% |
Anlon Healthcare Competitors Screener - Peer Comparison
Screen AHCL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 432,048 | 37.54 | 58,220 | 6.38% | 11,565 | 48.98 |
| Divis Laboratories | 178,196 | 69.40 | 10,560 | 8.73% | 2,520 | 54.23 |
| Torrent Pharmaceuticals | 151,173 | 70.66 | 13,886 | 20.34% | 2,138 | 53.30 |
| Cipla | 110,924 | 28.72 | 29,045 | 2.24% | 3,870 | 49.54 |
| Zydus Life Science | 108,543 | 21.18 | 26,720 | 13.65% | 5,242 | 59.73 |
| Dr Reddys Laboratories | 106,576 | 25.64 | 33,593 | -0.44% | 3,998 | 46.39 |
| Lupin | 104,105 | 19.44 | 27,488 | 19.98% | 5,345 | 50.04 |
| Mankind Pharma | 97,265 | 50.22 | 14,278 | 12.03% | 1,750 | 48.46 |
| Aurobindo Pharma | 81,121 | 23.13 | 33,385 | 3.21% | 3,376 | 38.66 |
| Laurus Labs | 74,306 | 83.49 | 6,868 | 22.01% | 890 | 57.68 |
Anlon Healthcare Company Announcements - News Screener
Screen AHCL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-17 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Invitation For TV Interview On NDTV Profit. | - |
| 2026-06-15 | Intimation Regarding Media Interaction Of Chairman & Managing Director | - |
| 2026-06-15 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-06-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-06-03 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-29 | Considered Approved And Taken On Record Audited Financial Results For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-29 | Board Meeting Outcome for To Consider And Approve Financial Results For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-23 | Board Meeting Intimation for To Consider And Approve The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 Along With The Auditors Report Thereon. | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-05-08 | Updates On Acquisition | - |
| 2026-04-27 | Announcements Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-04-27 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-04-22 | Intimation Of New ISIN | - |
| 2026-04-16 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | - |
| 2026-04-16 | Board Meeting Outcome for For Entered Into Share Purchase Agreement With Remember India Health Links Private Limited | - |
| 2026-04-15 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-04-15 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |